EDGAR Filing Documents for 0001144204-18-032045

Form 8-K - Current report:

SEC Accession No. 0001144204-18-032045

Filing Date

2018-05-31

Accepted

2018-05-31 17:10:33

Documents

Period of Report

2018-05-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tv495588_8k.htm	8-K	32435
2	EXHIBIT 10.1	tv495588_ex10-1.htm	EX-10.1	143764
3	EXHIBIT 99.1	tv495588_ex99-1.htm	EX-99.1	7358
4	EXHIBIT 99.2	tv495588_ex99-2.htm	EX-99.2	10373
5	GRAPHIC	image_001.jpg	GRAPHIC	5225
6	GRAPHIC	image_002.jpg	GRAPHIC	5225
	Complete submission text file	0001144204-18-032045.txt		210119

Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746

Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300

Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)